Cell therapy for multiple sclerosis: A new hope

Bioscience Horizons

Volumn 7, Issue , 2014, Pages

  Harbison, Sean ^a   Saffell, Jane ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Immunomodulation; Induced pluripotent stem cells; Neural stem cells; Neurodegeneration; Oligodendrocyte precursor cells; Remyelination

Indexed keywords

EID: 84957857017     PISSN: None     EISSN: 17547431     Source Type: Journal    
DOI: 10.1093/biohorizons/hzu014     Document Type: Review

References (131)

1. Akassoglou, K., Bauer, J., Kassiotis, G. et al. (1998) Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy, The American Journal of Pathology, 153 (3), 801-813.
2. Albert, M., Antel, J., Bruck, W. et al. (2007) Extensive cortical remyelination in patients with chronic multiple sclerosis, Brain Pathology (Zurich, Switzerland), 17 (2), 129-138.
3. Alvarez-Buylla, A. and Lim, D. A. (2004) For the long run: maintaining germinal niches in the adult brain, Neuron, 41 (5), 683-686.
4. Anderson, D. W., Ellenberg, J. H., Leventhal, C. M. et al. (1992) Revised estimate of the prevalence of multiple sclerosis in the United States, Annals of Neurology, 31 (3), 333-336.
5. Bai, L., Lennon, D. P., Eaton, V. et al. (2009) Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis, Glia, 57 (11), 1192-1203.
6. Bai, L., Lennon, D. P., Caplan, A. I. et al. (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models, Nature Neuroscience, 15 (6), 862-870.
7. Ben-Hur, T., Einstein, O., Mizrachi-Kol, R. et al. (2003) Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis, Glia, 41 (1), 73-80.
8. Bieber, A. J., Kerr, S. and Rodriguez, M. (2003) Efficient central nervous system remyelination requires T cells, Annals of Neurology, 53 (5), 680-684.
9. Bitsch, A., Schuchardt, J., Bunkowski, S. et al. (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation, Brain: A Journal of Neurology, 123 (Pt 6), 1174-1183.
10. Bjorklund, L. M., Sanchez-Pernaute, R., Chung, S. et al. (2002) Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model, Proceedings of the National Academy of Sciences of the United States of America, 99 (4), 2344-2349.
11. Blakemore, W. F. (1977) Remyelination of CNS axons by Schwann cells transplanted from the sciatic nerve, Nature, 266 (5597), 68-69.
12. Blakemore, W. F. and Franklin, R. J. (2008) Remyelination in experimental models of toxin-induced demyelination, Current Topics in Microbiology and Immunology, 318, 193-212.
13. Bonab, M. M., Sahraian, M. A., Aghsaie, A. et al. (2012) Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study, Current Stem Cell Research and Therapy, 7 (6), 407-414.
14. Bourdette, D. and Yadav, V. (2009) Alemtuzumab versus interferon beta- 1a in early multiple sclerosis, Current Neurology and Neuroscience Reports, 9 (5), 341-342.
15. Brinkmann, V., Billich, A., Baumruker, T. et al. (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis, Nature Reviews Drug Discovery, 9 (11), 883-897.
16. Brüstle, O., Jones, K. N., Learish, R. D. et al. (1999) Embryonic stem cellderived glial precursors: a source of myelinating transplants, Science, 285 (5428), 754-756.
17. Buljevac, D., Flach, H. Z., Hop, W. C. et al. (2002) Prospective study on the relationship between infections and multiple sclerosis exacerbations, Brain: A Journal of Neurology, 125 (Pt 5), 952-960.
18. CAMMS223 Trial Investigators, Coles, A. J., Compston, D. A. et al. (2008) Alemtuzumab vs. interferon beta-1a in early multiple sclerosis, The New England Journal of Medicine, 359 (17), 1786-1801.
19. Cohen, J. A., Barkhof, F., Comi, G. et al. (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis, The New England Journal of Medicine, 362 (5), 402-415.
20. Coles, A. J., Cox, A., Le Page, E. et al. (2006) The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy, Journal of Neurology, 253 (1), 98-108.
21. Comi, G., Martinelli, V., Rodegher, M. et al. (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double- blind, placebo-controlled trial, Lancet, 374 (9700), 1503-1511.
22. Comi, G., De Stefano, N., Freedman, M. S. et al. (2012) Comparison of two dosing frequencies of subcutaneous interferon beta-1a in patients with a first clinical demyelinating event suggestive of multiple sclerosis (REFLEX): a phase 3 randomised controlled trial, The Lancet Neurology, 11 (1), 33-41.
23. Connick, P., Kolappan, M., Crawley, C. et al. (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study, The Lancet Neurology, 11 (2), 150-156.
24. Davis, A. A. and Temple, S. (1994) A self-renewing multipotential stem cell in embryonic rat cerebral cortex, Nature, 372 (6503), 263-266.
25. Dennis, J. E., Merriam, A., Awadallah, A. et al. (1999) A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse, Journal of Bone and Mineral Research, 14 (5), 700-709.
26. Dziembowska, M., Tham, T. N., Lau, P. et al. (2005) A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors, Glia, 50 (3), 258-269.
27. Einstein, O., Fainstein, N., Vaknin, I. et al. (2007) Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression, Annals of Neurology, 61 (3), 209-218.
28. Einstein, O., Friedman-Levi, Y., Grigoriadis, N. et al. (2009) Transplanted neural precursors enhance host brain-derived myelin regeneration, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29 (50), 15694-15702.
29. Einstein, O., Karussis, D., Grigoriadis, N. et al. (2003) Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis, Molecular and Cellular Neurosciences, 24 (4), 1074-1082.
30. Fainstein, N., Einstein, O., Cohen, M. E. et al. (2013) Time limited immunomodulatory functions of transplanted neural precursor cells, Glia, 61 (2), 140-149.
31. Fandrich, F., Lin, X., Chai, G. X. et al. (2002) Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning, Nature Medicine, 8 (2), 171-178.
32. Fawcett, J. W. and Asher, R. A. (1999) The glial scar and central nervous system repair, Brain Research Bulletin, 49 (6), 377-391.
33. Ferrari, G., Cusella, G., Angelis, D. et al. (1998) Muscle regeneration by bone marrow-derived myogenic progenitors, Science, 279 (5356), 1528-1530.
34. Ffrench-Constant, C. and Raff, M. C. (1986) Proliferating bipotential glial progenitor cells in adult rat optic nerve, Nature, 319 (6053), 499-502.
35. Filippini, G., Del Giovane, C., Vacchi, L. et al. (2013) Immunomodulators and immunosuppressants for multiple sclerosis: a network metaanalysis, The Cochrane Database of Systematic Reviews, 6, CD008933.
36. Fischer, U. M., Harting, M. T., Jimenez, F. et al. (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect, Stem Cells and Development, 18 (5), 683-692.
37. Franklin, R. J. and Ffrench-Constant, C. (2010) Stem cell treatments and multiple sclerosis, BMJ (Clinical Research Ed.), 340, c1387.
38. Fridkis-Hareli, M., Teitelbaum, D., Gurevich, E. et al. (1994) Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells- specificity and promiscuity, Proceedings of the National Academy of Sciences of the United States of America, 91 (11), 4872-4876.
39. Friedenstein, A. J., Chailakhjan, R. K. and Lalykina, K. S. (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells, Cell and Tissue Kinetics, 3 (4), 393-403.
40. Gale, C. R. and Martyn, C. N. (1995) Migrant studies in multiple sclerosis, Progress in Neurobiology, 47 (4-5), 425-448.
41. Gerdoni, E., Gallo, B., Casazza, S. et al. (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis, Annals of Neurology, 61 (3), 219-227.
42. Glezer, I., Lapointe, A. and Rivest, S. (2006) Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries, FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 20 (6), 750-752.
43. Gordon, D., Pavlovska, G., Uney, J. B. et al. (2010) Human mesenchymal stem cells infiltrate the spinal cord, reduce demyelination, and localize to white matter lesions in experimental autoimmune encephalomyelitis, Journal of Neuropathology and Experimental Neurology, 69 (11), 1087-1095.
44. Gran, B., Tranquill, L. R., Chen, M. et al. (2000) Mechanisms of immunomodulation by glatiramer acetate, Neurology, 55 (11), 1704-1714.
45. Guo, B., Chang, E. Y. and Cheng, G. (2008) The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice, The Journal of Clinical Investigation, 118 (5), 1680-1690.
46. Hirsch, H. H., Kardas, P., Kranz, D. et al. (2013) The human JC polyomavirus (JCPyV): virological background and clinical implications, Acta Pathologica, Microbiologica, et Immunologica Scandinavica, 121 (8), 685-727.
47. Imitola, J., Raddassi, K., Park, K. I. et al. (2004) Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway, Proceedings of the National Academy of Sciences of the United States of America, 101 (52), 18117-18122.
48. Isele, N. B., Lee, H. S., Landshamer, S. et al. (2007) Bone marrow stromal cells mediate protection through stimulation of PI3-K/Akt and MAPK signaling in neurons, Neurochemistry International, 50 (1), 243-250.
49. Iwanami, A., Kaneko, S., Nakamura, M. et al. (2005) Transplantation of human neural stem cells for spinal cord injury in primates, Journal of Neuroscience Research, 80 (2), 182-190.
50. Jacobs, L. D., Beck, R. W., Simon, J. H. et al. (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group, The New England Journal of Medicine, 343 (13), 898-904.
51. Jaramillo-Merchan, J., Jones, J., Ivorra, J. L. et al. (2013) Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model, Cell Death and Disease, 4, e779.
52. Jeong, S. R., Kwon, M. J., Lee, H. G. et al. (2012) Hepatocyte growth factor reduces astrocytic scar formation and promotes axonal growth beyond glial scars after spinal cord injury, Experimental Neurology, 233 (1), 312-322.
53. Jiang, X. X., Zhang, Y., Liu, B. et al. (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells, Blood, 105 (10), 4120-4126.
54. Johnson, K. P., Brooks, B. R., Cohen, J. A. et al. (1995) Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebocontrolled trial. The Copolymer 1 Multiple Sclerosis Study Group, Neurology, 45 (7), 1268-1276.
55. Johnson, K. P., Brooks, B. R., Cohen, J. A. et al. (1998) Extended use of glatiramer acetate (Copaxone) is well tolerated and maintains its clinical effect on multiple sclerosis relapse rate and degree of disability. Copolymer 1 Multiple Sclerosis Study Group, Neurology, 50 (3), 701-708.
56. Kanakasabai, S., Pestereva, E., Chearwae, W. et al. (2012) PPARgamma agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes, PloS ONE, 7 (11), e50500.
57. Kappos, L., Polman, C. H., Freedman, M. S. et al. (2006) Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes, Neurology, 67 (7), 1242-1249.
58. Kappos, L., Radue, E. W., O'Connor, P. et al. (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis, The New England Journal of Medicine, 362 (5), 387-401.
59. Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A. et al. (2010) Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis, Archives of Neurology, 67 (10), 1187-1194.
60. Keirstead, H. S., Nistor, G., Bernal, G. et al. (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury, The Journal of Neuroscience, 25 (19), 4694-4705.
61. Kemp, K., Hares, K., Mallam, E. et al. (2010) Mesenchymal stem cellsecreted superoxide dismutase promotes cerebellar neuronal survival, Journal of Neurochemistry, 114 (6), 1569-1580.
62. Kerschensteiner, M., Stadelmann, C., Dechant, G. et al. (2003) Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases, Annals of Neurology, 53 (3), 292-304.
63. Kopen, G. C., Prockop, D. J. and Phinney, D. G. (1999) Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains, Proceedings of the National Academy of Sciences, 96 (19), 10711-10716.
64. Kozovska, M. E., Hong, J., Zang, Y. C. et al. (1999) Interferon beta induces T-helper 2 immune deviation in MS, Neurology, 53 (8), 1692-1697.
65. Kuznetsov, S. A., Friedenstein, A. J. and Gehron Robey, P. (1997) Factors required for bone marrow stromal fibroblast colony formation in vitro, British Journal of Haematology, 97 (3), 561-570.
66. Lassmann, H. (2007) Multiple sclerosis: is there neurodegeneration independent from inflammation? Journal of the Neurological Sciences, 259 (1-2), 3-6.
67. Laterza, C., Merlini, A., De Feo, D. et al. (2013) iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF, Nature Communications, 4, 2597.
68. Leary, S. M., Miller, D. H., Stevenson, V. L. et al. (2003) Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial, Neurology, 60 (1), 44-51.
69. Li, Y., Chu, N., Hu, A. et al. (2007) Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia, Brain: A Journal of Neurology, 130 (Pt 2), 490-501.
70. Lipton, H. L. (1975) Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination, Infection and Immunity, 11 (5), 1147-1155.
71. Liu, Z., Pelfrey, C. M., Cotleur, A. et al. (2001) Immunomodulatory effects of interferon beta-1a in multiple sclerosis, Journal of Neuroimmunology, 112 (1-2), 153-162.
72. Liu, H., Ye, Z., Kim, Y. et al. (2010) Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes, Hepatology (Baltimore, Md.), 51 (5), 1810-1819.
73. Lu, P., Jones, L. L., Snyder, E. Y. et al. (2003) Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury, Experimental Neurology, 181 (2), 115-129.
74. Lublin, F. D. and Reingold, S. C. (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology, 46 (4), 907-911.
75. Lucchinetti, C. F., Parisi, J. and Bruck, W. (2005) The pathology of multiple sclerosis, Neurologic Clinics, 23 (1), 77-105, vi.
76. Lykissas, M. G., Batistatou, A. K., Charalabopoulos, K. A. et al. (2007) The role of neurotrophins in axonal growth, guidance, and regeneration, Current Neurovascular Research, 4 (2), 143-151.
77. Martino, G. and Pluchino, S. (2006) The therapeutic potential of neural stem cells, Nature Reviews Neuroscience, 7 (5), 395-406.
78. Matloubian, M., Lo, C. G., Cinamon, G. et al. (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1, Nature, 427 (6972), 355-360.
79. Metz, I., Weigand, S. D., Popescu, B. F. et al. (2014) Pathologic heterogeneity persists in early active multiple sclerosis lesions, Annals of Neurology, 75 (5), 728-738.
80. Mfopou, J. K., Geeraerts, M., Dejene, R. et al. (2014) Efficient definitive endoderm induction from mouse embryonic stem cell adherent cultures: a rapid screening model for differentiation studies, Stem Cell Research, 12 (1), 166-177.
81. Munoz, J. R., Stoutenger, B. R., Robinson, A. P. et al. (2005) Human stem/ progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice, Proceedings of the National Academy of Sciences of the United States of America, 102 (50), 18171-18176.
82. Muraro, P. A., Leist, T., Bielekova, B. et al. (2000) VLA-4/CD49d downregulated on primed T lymphocytes during interferon-beta therapy in multiple sclerosis, Journal of Neuroimmunology, 111 (1-2), 186-194.
83. Nait-Oumesmar, B., Picard-Riera, N., Kerninon, C. et al. (2007) Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors, Proceedings of the National Academy of Sciences of the United States of America, 104 (11), 4694-4699.
84. Nistor, G. I., Totoiu, M. O., Haque, N. et al. (2005) Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation, Glia, 49 (3), 385-396.
85. Oeda, S., Hayashi, Y., Chan, T. et al. (2013) Induction of intermediate mesoderm by retinoic acid receptor signaling from differentiating mouse embryonic stem cells, The International Journal of Developmental Biology, 57 (5), 383-389.
86. Olerup, O. and Hillert, J. (1991) HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation, Tissue Antigens, 38 (1), 1-15.
87. Ozenci, V., Kouwenhoven, M., Huang, Y. M. et al. (1999) Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment, Scandinavian Journal of Immunology, 49 (5), 554-561.
88. Pan, Y. W., Storm, D. R. and Xia, Z. (2013) Role of adult neurogenesis in hippocampus-dependent memory, contextual fear extinction and remote contextual memory: new insights from ERK5 MAP kinase, Neurobiology of Learning and Memory, 105, 81-92.
89. Patani, R., Balaratnam, M., Vora, A. et al. (2007) Remyelination can be extensive in multiple sclerosis despite a long disease course, Neuropathology and Applied Neurobiology, 33 (3), 277-287.
90. Paty, D. W. and Li, D. K. (1993) Interferon beta-1b is effective in relapsingremitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group, Neurology, 43 (4), 662-667.
91. Pereira, R. F., Halford, K. W., O'Hara, M. D. et al. (1995) Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice, Proceedings of the National Academy of Sciences, 92 (11), 4857-4861.
92. Picard-Riera, N., Decker, L., Delarasse, C. et al. (2002) Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice, Proceedings of the National Academy of Sciences of the United States of America, 99 (20), 13211-13216.
93. Pirko, I., Ciric, B., Gamez, J. et al. (2004a) A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS, FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 18 (13), 1577-1579.
94. Pirko, I., Gamez, J., Johnson, A. J. et al. (2004b) Dynamics of MRI lesion development in an animal model of viral-induced acute progressive CNS demyelination, NeuroImage, 21 (2), 576-582.
95. Pirko, I., Johnson, A. J., Lohrey, A. K. et al. (2009) Deep gray matter T2 hypointensity correlates with disability in a murine model of MS, Journal of the Neurological Sciences, 282 (1-2), 34-38.
96. Pluchino, S., Quattrini, A., Brambilla, E. et al. (2003) Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis, Nature, 422 (6933), 688-694.
97. Pluchino, S., Gritti, A., Blezer, E. et al. (2009a) Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates, Annals of Neurology, 66 (3), 343-354.
98. Pluchino, S., Zanotti, L., Brambilla, E. et al. (2009b) Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function, PloS ONE, 4 (6), e5959.
99. Polman, C. H., O'Connor, P. W., Havrdova, E. et al. (2006) A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis, The New England Journal of Medicine, 354 (9), 899-910.
100. Ramgolam, V. S., Sha, Y., Jin, J. et al. (2009) IFN-beta inhibits human Th17 cell differentiation, Journal of immunology (Baltimore, Md.: 1950), 183 (8), 5418-5427.
101. Rampon, C., Weiss, N., Deboux, C. et al. (2008) Molecular mechanism of systemic delivery of neural precursor cells to the brain: assembly of brain endothelial apical cups and control of transmigration by CD44, Stem Cells (Dayton, Ohio), 26 (7), 1673-1682.
102. Rhodes, K. E., Raivich, G. and Fawcett, J. W. (2006) The injury response of oligodendrocyte precursor cells is induced by platelets, macrophages and inflammation-associated cytokines, Neuroscience, 140 (1), 87-100.
103. Rice, C. M. and Scolding, N. J. (2010) Adult human mesenchymal cells proliferate and migrate in response to chemokines expressed in demyelination, Cell Adhesion and Migration, 4 (2), 235-240.
104. Rivera, F. J., Siebzehnrubl, F. A., Kandasamy, M. et al. (2009) Mesenchymal stem cells promote oligodendroglial differentiation in hippocampal slice cultures, Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 24 (3-4), 317-324.
105. Rojas, J. I., Romano, M., Ciapponi, A. et al. (2009) Interferon beta for primary progressive multiple sclerosis, The Cochrane Database of Systematic Reviews, 1, CD006643.
106. Rosenbluth, J., Hasegawa, M., Shirasaki, N. et al. (1990) Myelin formation following transplantation of normal fetal glia into myelin-deficient rat spinal cord, Journal of Neurocytology, 19 (5), 718-730.
107. Sadovnick, A. D., Ebers, G. C., Dyment, D. A. et al. (1996) Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group, Lancet, 347 (9017), 1728-1730.
108. Sakurai, H., Sakaguchi, Y., Shoji, E. et al. (2012) In vitro modeling of paraxial mesodermal progenitors derived from induced pluripotent stem cells, PloS ONE, 7 (10), e47078.
109. Scalfari, A., Knappertz, V., Cutter, G. et al. (2013) Mortality in patients with multiple sclerosis, Neurology, 81 (2), 184-192.
110. Siffrin, V., Vogt, J., Radbruch, H. et al. (2010) Multiple sclerosis - candidate mechanisms underlying CNS atrophy, Trends in Neurosciences, 33 (4), 202-210.
111. Skripuletz, T., Gudi, V., Hackstette, D. et al. (2011) De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected, Histology and Histopathology, 26 (12), 1585-1597.
112. Surmacz, B., Fox, H., Gutteridge, A. et al. (2012) Directing differentiation of human embryonic stem cells toward anterior neural ectoderm using small molecules, Stem Cells (Dayton, Ohio), 30 (9), 1875-1884.
113. Teng, Y. D., Yu, D., Ropper, A. E. et al. (2011) Functional multipotency of stem cells: a conceptual review of neurotrophic factor-based evidence and its role in translational research, Current Neuropharmacology, 9 (4), 574-585.
114. The IFNB Multiple Sclerosis Study. (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group, Neurology, 43 (4), 655-661.
115. Thier, M., Worsdorfer, P., Lakes, Y. B. et al. (2012) Direct conversion of fibroblasts into stably expandable neural stem cells, Cell Stem Cell, 10 (4), 473-479.
116. van Engelen, B. G., Miller, D. J., Pavelko, K. D. et al. (1994) Promotion of remyelination by polyclonal immunoglobulin in Theiler's virusinduced demyelination and in multiple sclerosis., Journal of Neurology, Neurosurgery and Psychiatry, 57 (Suppl), 65-68.
117. Veraitch, O., Kobayashi, T., Imaizumi, Y. et al. (2013) Human induced pluripotent stem cell-derived ectodermal precursor cells contribute to hair follicle morphogenesis in vivo, The Journal of Investigative Dermatology, 133 (6), 1479-1488.
118. Waksman, B. H. and Adams, R. D. (1962) A histologic study of the early lesion in experimental allergic encephalomyelitis in the guinea pig and rabbit, The American Journal of Pathology, 41, 135-162.
119. Warrington, A. E., Barbarese, E. and Pfeiffer, S. E. (1993) Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts, Journal of Neuroscience Research, 34 (1), 1-13.
120. Windrem, M. S., Nunes, M. C., Rashbaum, W. K. et al. (2004) Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain, Nature Medicine, 10 (1), 93-97.
121. Windrem, M. S., Schanz, S. J., Guo, M. et al. (2008) Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse, Cell Stem Cell, 2 (6), 553-565.
122. Wolinsky, J. S., Narayana, P. A., O'Connor, P. et al. (2007) Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trial, Annals of Neurology, 61 (1), 14-24.
123. Xing, Y. L., Roth, P. T., Stratton, J. A. et al. (2014) Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination, The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 34 (42), 14128-14146.
124. Yamanaka, S. and Takahashi, K. (2006) Induction of pluripotent stem cells from mouse fibroblast cultures, Tanpakushitsu kakusan koso. Protein, Nucleic Acid, Enzyme, 51 (15), 2346-2351.
125. Yandava, B. D., Billinghurst, L. L. and Snyder, E. Y. (1999) Global cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain, Proceedings of the National Academy of Sciences of the United States of America, 96 (12), 7029-7034.
126. Yang, N., Zuchero, J. B., Ahlenius, H. et al. (2013) Generation of oligodendroglial cells by direct lineage conversion, Nature Biotechnology, 31 (5), 434-439.
127. Yednock, T. A., Cannon, C., Fritz, L. C. et al. (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin, Nature, 356 (6364), 63-66.
128. Young, R. G., Butler, D. L., Weber, W. et al. (1998) Use of mesenchymal stem cells in a collagen matrix for achilles tendon repair, Journal of Orthopaedic Research, 16 (4), 406-413.
129. Zamvil, S., Nelson, P., Trotter, J. et al. (1985) T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination, Nature, 317 (6035), 355-358.
130. Zhang, L., Yuan, S., Cheng, G. et al. (2011) Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation, PloS ONE, 6 (12), e28432.
131. Zoecklein, L. J., Pavelko, K. D., Gamez, J. et al. (2003) Direct comparison of demyelinating disease induced by the Daniel's strain and BeAn strain of Theiler's murine encephalomyelitis virus, Brain Pathology (Zurich, Switzerland), 13 (3), 291-308.